May 28, 2012 A federal task force's recommendations against routine blood tests for prostate cancer raises big questions about how to interpret medical evidence and what role expert panels should play in how doctors practice. But those questions aren't easy to answer.
<iframe src="http://www.npr.org/player/embed/153879847/153883324" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
May 24, 2012 Johns Hopkins researcher round that nearly three-quarters of primary care doctors they surveyed said their patients expected regular PSA screening to continue. The findings suggest there will be
May 23, 2012 The U.S. Preventive Services Task Force said the harms, such as false alarms and unnecessary surgeries that leave some men impotent and incontinent, outweigh the benefits of routine PSA blood testing for prostate cancer. But it's far from clear that doctors and their patients will heed the advice.
Terry Dyroff, at home in Silver Spring, Md., got a PSA blood test that led to a prostate biopsy. The biopsy found no cancer, but it gave him a life-threatening infection.
Jose Luis Magana/AP
May 21, 2012 The U.S. Preventive Services Task Force says the testing doesn't save enough lives to justify the risk of unnecessary surgery and radiation. But one testing supporter says, "If all PSA screening were to stop, there would be thousands of men who would unnecessarily suffer and die from prostate cancer."
<iframe src="http://www.npr.org/player/embed/153234671/153224081" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
April 23, 2012 Dr. Otis Brawley, chief medical officer for the American Cancer Society, gave a fiery speech at annual meeting of Association of Health Care Journalists over the weekend. It was a no-holds-barred critique of the U.S. system of health care.
April 18, 2012 Billionaire Warren Buffett was tested for prostate cancer at an age when most men are not. The evidence suggests that in most cases the harms of treatment of prostate cancer in elderly men outweigh its benefits.
October 26, 2011 Confused about the fuss over PSA screening for prostate cancer? A commentary in the New England Journal of medicine says there's a middle ground between business-as-usual and throwing PSA tests out altogether.
Former House Speaker Newt Gingrich makes a point during the presidential debate sponsored at Dartmouth College in Hanover, New Hampshire, Tuesday night.
October 12, 2011 Newt Gingrich invoked Dr. Andrew von Eschenbach, former head of the National Cancer Institute, in criticizing proposed changes in prostate cancer screening. A close watcher of von Eschenbach at NCI questioned whether he is the right person to lean on.
Chicago attorney Tom Hayward suffered a raging infection after a prostate biopsy. He had to be hospitalized, but has since recovered.
October 7, 2011 Routine testing of men's blood to detect prostate cancer is unwarranted, and causes more harm than good, according to findings of the U.S. Preventive Services Task Force. The panel of experts sets the agenda for doctors and, increasingly, insurance payments.
<iframe src="http://www.npr.org/player/embed/141148384/141162175" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
November 30, 2009 Yes, you really heard what you thought you heard: The new CBS Cares campaign advocates giving appointments for pap smears as holiday gifts.
NPR thanks our sponsors
Become an NPR sponsor